Dendrite Clinical Systems in the Press
Over the years, the outcomes from Dendrite’s registries and clinical trials have frequently featured in the media. Examples include (by specialty):
Bariatric (NBSR)
- BBC - Many young weight-loss surgery patients 'super-obese'
- RCSEng - RCS comment on the launch of second NBSR report
Cardiothoracic surgery
COVID
- FORECAST - BBC - Coronavirus: Loss of smell may be clearer sign than cough
- CoviDiab
- The Times - Covid can trigger diabetes, growing evidence suggests
- Scientific American - Unraveling the Complex Link between COVID and Diabetes
- MSNBC (Today) - Can COVID-19 cause diabetes?
- Fox News - COVID-19 may trigger diabetes in some people
- The Independent - Coronavirus may trigger diabetes in previously healthy people, scientists fear
Interventional Radiology (ROPE Registry)
Medical Cannabis Registry
Orthopaedics (QIST)
Vascular (VASCUNET Report)
Consultant Outcomes Portals
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


